Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4676
Skywest
SKYW
$4.5B
| $130K | ﹤0.01% |
2,962
-10,944
| -79% | -$409K |
|
|
XONE
4677
PUT
DELISTED
The ExOne Company
XONE
| $130K | ﹤0.01% |
11,400
-12,100
| -51% | -$119K |
|
|
CEMP
4678
DELISTED
Cempra, Inc.
CEMP
| $130K | ﹤0.01% |
39,984
-34,990
| -47% | -$124K |
|
4679
PUT
BioCryst Pharmaceuticals
BCRX
$2.31B
| $129K | ﹤0.01% |
24,700
+5,700
| +30% | +$29.2K |
|
4680
Forrester Research
FORR
$226M
| $129K | ﹤0.01% |
3,076
-1,804
| -37% | -$72.7K |
|
4681
PUT
HUB Group
HUBG
$2.91B
| $129K | ﹤0.01% |
+6,000
| New | +$115K |
|
4682
PUT
Leggett & Platt
LEG
$1.4B
| $129K | ﹤0.01% |
2,700
+2,200
| +440% | +$106K |
|
4683
ProPetro Holding
PUMP
$1.35B
| $129K | ﹤0.01% |
8,999
+4,243
| +89% | +$53.3K |
|
4684
Upland Software
UPLD
$12.8M
| $129K | ﹤0.01% |
610
+609
| +60,900% | +$140K |
|
4685
Globant
GLOB
$1.66B
| $128K | ﹤0.01% |
3,181
-62,953
| -95% | -$2.6M |
|
4686
MarketAxess Holdings
MKTX
$5.71B
| $128K | ﹤0.01% |
698
-1,864
| -73% | -$357K |
|
4687
CALL
NewMarket
NEU
$8.11B
| $128K | ﹤0.01% |
300
+100
| +50% | +$43.6K |
|
4688
Omeros
OMER
$916M
| $128K | ﹤0.01% |
5,914
-2,687
| -31% | -$56.9K |
|
4689
Comstock Resources
CRK
$3.81B
| $127K | ﹤0.01% |
20,870
-21,931
| -51% | -$142K |
|
4690
iShares Global Energy ETF
IXC
$2.75B
| $127K | ﹤0.01% |
3,737
| – | – |
|
|
ZEUS
4691
DELISTED
Olympic Steel
ZEUS
| $127K | ﹤0.01% |
5,754
+1,190
| +26% | +$21.9K |
|
|
EWGS
4692
DELISTED
iShares MSCI Germany Small-Cap ETF
EWGS
| $127K | ﹤0.01% |
+2,104
| New | +$119K |
|
|
HNP
4693
PUT
DELISTED
Huaneng Power Intl, Inc.
HNP
| $127K | ﹤0.01% |
5,200
+3,400
| +189% | +$90.1K |
|
|
NUAN
4694
PUT
DELISTED
Nuance Communications, Inc.
NUAN
| $127K | ﹤0.01% |
9,356
+462
| +5% | +$6.6K |
|
|
IMDZ
4695
DELISTED
Immune Design Corp.
IMDZ
| $127K | ﹤0.01% |
12,296
+12,284
| +102,367% | +$121K |
|
4696
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.97B
| $126K | ﹤0.01% |
5,181
-2,540
| -33% | -$59.5K |
|
4697
CALL
Vanda Pharmaceuticals
VNDA
$306M
| $125K | ﹤0.01% |
7,000
+6,900
| +6,900% | +$115K |
|
|
ARAV
4698
DELISTED
Aravive, Inc. Common Stock
ARAV
| $125K | ﹤0.01% |
8,459
+7,940
| +1,530% | +$801K |
|
|
LQ
4699
DELISTED
La Quinta Holdings Inc.
LQ
| $125K | ﹤0.01% |
7,147
+7,045
| +6,907% | +$109K |
|
4700
PUT
Fomento Económico Mexicano
FMX
$42.4B
| $124K | ﹤0.01% |
1,300
-6,900
| -84% | -$687K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.